
































































































































































Ingredients Intact/CA IF Arg IFA
Isoflavoneextracted 0.0 2.0 0.0 2.0
L-Arginine 0.0 0.0 12.0 12.0
Casein 220.0 220.0 220.0 220.0
・-Cornstarch 406.7 405.3 398.7 397.3
Sucrose 203.3 202.7 199.3 198.7
Celulosepowder 50.0 50.0 50.0 50.0
Mineralmixture 50.0 50.0 50.0 50.0
Vitaminmixture 20.0 20.0 20.0 20.0
Cornoil 50.0 50.0 50.0 50.0
















































































































CA 6 29.4±2.5a 5.9±1.0a 3.2±0.2a
IF 6 31.3±2.9a 6.3±0.6a 3.0±0.2a
Arg 6 25.4±1.7a 5.5±0.4a 3.0±0.1a
IFA 5 29.4±1.0a 5.7±0.6a 3.1±0.4a









Group n TP ALB GOT GPT
g/100ml g/100ml U U
CA 6 8.3±1.1a 4.0±0.1a 60±19a 18±6a
IF 6 8.3±0.7a 4.0±0.3a 56±23a 17±6a
Arg 6 7.4±0.4a 3.9±0.2a 60±10a 15±2a
IFA 5 7.8±0.2a 4.3±0.2a 60±24a 21±8a
Intact 6 8.2±0.7ns 4.3±0.2ns 90±34＊ 23±11a
Group n Calcium T-chol TG
mg/100ml mg/100ml mg/100ml
CA 6 10.6±0.4a 107±8a 92±45a
IF 6 10.8±0.3a 80±15b 96±25a
Arg 6 10.4±0.2a 103±16a 69±12a
IFA 5 10.7±0.5a 93±22ab 73±8a








Group n S-Creat U-Creat CCr BUN
mg/100ml mg/day ml/min mg/100ml
CA 6 1.54±0.19a 8.6±1.8a 0.396±0.111a 43.1±7.4a
IF 6 1.44±0.29a 8.7±1.2a 0.433±0.110a 38.1±13.8ab
Arg 6 1.48±0.11a 11.6±1.3b 0.551±0.100b 33.2±4.2b
IFA 5 1.71±0.33a 10.0±1.1ab 0.427±0.138a 49.4±9.2a


























































Group n NAG U-Prot
U/gCreat mg/day
CA 6 27.0±6.3a 25.9±6.6ab
IF 6 24.9±4.5ab 33.9±6.8b
Arg 6 20.5±4.3ab 17.4±3.6c
IFA 5 20.4±2.4b 24.0±6.8ac





























































Group n Cortical-BMD Cancelous-BMD Polarmomentofinertia
mg/cm3 mg/cm3
CA 6 1124±23a 392±29a 4.50±0.49a
IF 6 1139±5a 430±16b 4.71±0.42a
Arg 6 1131±15a 392±9ac 4.69±0.38a
IFA 5 1127±6a 433±20b 4.69±0.42a
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